Neuralink's Breakthrough: FDA Approves First-in-Human Clinical Study

In a significant milestone for the field of neurotechnology, Neuralink has announced that it has received approval from the U.S. Food and Drug Administration (FDA) to launch its first-in-human clinical study. This achievement comes as a result of the exceptional work conducted by the Neuralink team in collaboration with the FDA. The approval marks a cru…